PCI Biotech Holding ASA (OSL:PCIB)
Norway flag Norway · Delayed Price · Currency is NOK
1.330
-0.068 (-4.86%)
Apr 2, 2025, 1:19 PM CET

PCI Biotech Holding ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
524478775191,041
Upgrade
Market Cap Growth
-43.29%-43.29%2.20%-85.26%-50.14%-63.57%
Upgrade
Enterprise Value
25143311386832
Upgrade
Last Close Price
1.401.192.102.0513.9127.90
Upgrade
PS Ratio
7.746.5826.1516.1182.77141.34
Upgrade
PB Ratio
2.221.892.001.334.565.50
Upgrade
P/TBV Ratio
1.891.892.001.334.565.50
Upgrade
EV/Sales Ratio
3.782.1211.102.2661.49112.91
Upgrade
Debt / Equity Ratio
0.010.010.010.010.020.00
Upgrade
Asset Turnover
0.180.180.060.050.040.03
Upgrade
Quick Ratio
3.983.988.8010.915.809.77
Upgrade
Current Ratio
3.983.988.8010.916.1410.13
Upgrade
Return on Equity (ROE)
-52.54%-52.54%-42.13%-64.37%-58.34%-32.53%
Upgrade
Return on Assets (ROA)
-29.82%-29.82%-25.85%-35.38%-31.16%-20.90%
Upgrade
Return on Capital (ROIC)
-35.54%-35.54%-28.50%-40.58%-35.19%-23.02%
Upgrade
Earnings Yield
-31.46%-37.02%-25.98%-72.00%-17.02%-6.94%
Upgrade
FCF Yield
-31.03%-31.03%-19.14%-77.16%-13.22%-7.81%
Upgrade
Buyback Yield / Dilution
0.04%0.04%---0.11%0.01%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.